Inclusion Criteria:  Age 18 or older Opioid use in the past 30 days DSM-5 diagnostic criteria for OUD with physiological dependence Willing to try buprenorphine treatment.  Exclusion Criteria:  current enrollment in OUD treatment with buprenorphine, methadone, or extended-release naltrexone clinical contraindication with buprenorphine (e.g., allergy to buprenorphine or naloxone, chronic pain management with opioid agonists) regular use of illicit long-acting opioid agonists (e.g., methadone; due to potential challenges with dose induction) heavy alcohol use that, in the judgement of the prescribing provider, raises a safety concern that precludes eligibility for buprenorphine induction high dose or intravenous benzodiazepine misuse pregnancy (due to special needs; will be treated outside of the study) unstable medical or psychiatric illness (e.g., psychosis or active suicidal ideation) inability to provide informed consent (e.g., failure to pass consent quiz)